Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

Clinical trial NCT02230059 · COMPLETED

Trial details

NCT number: NCT02230059
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Neoplasms

Start date: 2013-07-01
Primary completion: 2014-05-01
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.